Neurorehabilitation Devices Market: By Product Type, By Disease Type, By End-User, and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Neurorehabilitation Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Non-invasive Stimulators, Wearable Devices, Neurorobotic System, Brain-computer Interface), By Disease Type (Brain Stroke, Parkinson's Disease, Cerebral Palsy, Traumatic Brain Injury, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers), and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Neurorehabilitation Devices Market size was valued at US$ 2.39 billion in 2024 and is expected to reach US$ 5.43 billion by 2031, growing at a significant CAGR of 12.4% from 2025-2031. Neurorehabilitation is the medical procedure that aims to recover the nervous system injury that results in the functional nervous system from the non-functional nervous system and improve the well-being of an individual. Neurorehabilitation devices are used in Parkinson's disease, cerebral palsy, multiple sclerosis, stroke recovery, and brain injury among others. The neurorehabilitation procedure allows for the reduction of deficits and impairments, thereby enhancing the patient's quality of life.

Neurorehabilitation devices include invasive stimulators, non-invasive stimulators, neurorobotics, and brain-computer interfaces. Global market exhibiting lucrative growth owing to increase in the prevalence of neurovascular diseases. According to World Health Organization 2014, approximately 15 Mn people are affected with neurological disorders each year, from which approximately 5 Mn people suffer from permanent disability. Moreover, market players are actively involved in the development of innovative products with novel technologies such as nanotechnology, wearable technology, robotics, and other non-invasive technologies to garner larger market share. In addition, acquisitions and mergers between the market players is a key strategy adopted by market players for generating larger revenue in neurorehabilitation market.

Key Developments:

  • in March 2016, Bionik Laboratories Corp. inked a merger agreement with Interactive Motion technologies, Inc. for expanding the company's neurorehabilitation devices portfolio.
  • In October 2017, Civitas Solution acquired Mentis Neuro Rehabilitation, LLC for the expansion of business in neurorehabilitation devices

summary download arrow Download Sample

Neurorehabilitation Devices Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

12.4%

Largest Market

North-America

Fastest Growing Market

Europe

Neurorehabilitation Devices Market Dynamics

Increase in the prevalence of neurological diseases such as brain injury and Parkinson's disease, rise in preference for minimally invasive procedures, technological advancements in the neurorehabilitation devices, and favorable reimbursement policies are anticipated to fuel the neurorehabilitation devices market over the forecast period.

Moreover, rise in R&D for the innovation of newer products, increase in geriatric population, and rise in healthcare expenditure, and advancements in robotic surgery are anticipated to boost the market over the forecast period. However, high cost of devices, stringent regulatory policies for product approval, and product recall may hamper the growth of market over the forecast years.

Neurorehabilitation Devices Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 2.39 billion

Market Size in 2031

US$ 5.43 billion

Market CAGR

12.4%

By Product Type

  • Non-invasive Stimulators
  • Wearable Devices
  • Neurorobotic System
  • Brain-computer Interface

By Disease Type

  • Brain Stroke
  • Parkinson’s Disease
  • Cerebral Palsy
  • Traumatic Brain Injury
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The neurorehabilitation devices market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global neurorehabilitation devices market size was valued at US$ 2.39 billion in 2024 and is projected to grow at a CAGR of 12.4% from 2025 to 2031.

Medtronic, Abbott Laboratories, Hocoma AG, Ekso Bionics Holding Inc.

Europe is the fastest-growing region for market.

Key opportunities for the market include the growing aging population, increasing prevalence of neurological disorders, and advancements in technology enabling more effective and personalized rehabilitation therapies.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Neurorehabilitation Devices Market Introduction 
2.1.Global Neurorehabilitation Devices Market  - Taxonomy
2.2.Global Neurorehabilitation Devices Market  - Definitions
2.2.1.Product Type
2.2.2.Disease Type
2.2.3.End User
2.2.4.Region
3.Global Neurorehabilitation Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Neurorehabilitation Devices Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Neurorehabilitation Devices Market  By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Non-invasive Stimulators
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Wearable Devices
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Neurorobotic System
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Brain-computer Interface
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Neurorehabilitation Devices Market  By Disease Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Brain Stroke
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Parkinson’s Disease
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cerebral Palsy
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Traumatic Brain Injury
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Neurorehabilitation Devices Market  By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Neurorehabilitation Devices Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Neurorehabilitation Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Non-invasive Stimulators
9.1.2.Wearable Devices
9.1.3.Neurorobotic System
9.1.4.Brain-computer Interface
9.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Brain Stroke
9.2.2.Parkinson’s Disease
9.2.3.Cerebral Palsy
9.2.4.Traumatic Brain Injury
9.2.5.Others
9.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Ambulatory Surgical Centers
9.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Neurorehabilitation Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Non-invasive Stimulators
10.1.2.Wearable Devices
10.1.3.Neurorobotic System
10.1.4.Brain-computer Interface
10.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Brain Stroke
10.2.2.Parkinson’s Disease
10.2.3.Cerebral Palsy
10.2.4.Traumatic Brain Injury
10.2.5.Others
10.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Ambulatory Surgical Centers
10.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Neurorehabilitation Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Non-invasive Stimulators
11.1.2.Wearable Devices
11.1.3.Neurorobotic System
11.1.4.Brain-computer Interface
11.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Brain Stroke
11.2.2.Parkinson’s Disease
11.2.3.Cerebral Palsy
11.2.4.Traumatic Brain Injury
11.2.5.Others
11.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Ambulatory Surgical Centers
11.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Neurorehabilitation Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Non-invasive Stimulators
12.1.2.Wearable Devices
12.1.3.Neurorobotic System
12.1.4.Brain-computer Interface
12.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Brain Stroke
12.2.2.Parkinson’s Disease
12.2.3.Cerebral Palsy
12.2.4.Traumatic Brain Injury
12.2.5.Others
12.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Ambulatory Surgical Centers
12.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Neurorehabilitation Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Non-invasive Stimulators
13.1.2.Wearable Devices
13.1.3.Neurorobotic System
13.1.4.Brain-computer Interface
13.2.  Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Brain Stroke
13.2.2.Parkinson’s Disease
13.2.3.Cerebral Palsy
13.2.4.Traumatic Brain Injury
13.2.5.Others
13.3.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Ambulatory Surgical Centers
13.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Medtronic plc (Ireland)
14.2.2.Abbott Laboratories (U.S.)
14.2.3.Hocoma AG (DIH International Ltd.) (Switzerland)
14.2.4.Ekso Bionics Holding Inc. (U.S.)
14.2.5.Interactive Motion Technologies (U.S.)
14.2.6.Bionik laboratories Corp. (Canada)
14.2.7.Tyromotion (Austria)
14.2.8.Bioxtreme Robotics Rehabilitation (Israel)
14.2.9.Civitas Solutions (U.S.)
14.2.10.Neurostyle Pte Ltd. (Singapore)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Medtronic plc
  • Abbott Laboratories
  • Hocoma AG (DIH International Ltd.)
  • Ekso Bionics Holding Inc.
  • Interactive Motion Technologies
  • Bionik laboratories Corp.
  • Tyromotion
  • Bioxtreme Robotics Rehabilitation
  • Civitas Solutions
  • Neurostyle Pte Ltd.

Related Industry Reports

Outpatient Rehabilitation Centers Market

Global Neurological Disorder Diagnostics Market

Neuronavigation Systems Market

Global Interventional Neurology Devices Market